Amplia Therapeutics Limited (ATX, formerly Innate Immunotherapeutics Limited) is an Australian pharmaceutical company that is advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. FAK is an increasingly important target in the field of cancer immunology and Amplia has a particular development focus in pancreatic and ovarian cancer. FAK also plays a significant role in a number of chronic diseases, such as idiopathic pulmonary fibrosis (IPF).
Amplia Therapeutics Limited operators in Health Care sector and under industry of Biotechnology. The company website is: http://www.ampliatx.com.
You can also check out dividend history for similar stocks in the same sector as follows:
ATX Dividend Dates
Please click the table header to sort the data.
No Dividend Dates Found